Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Association of income and prescription drug coverage with generic medication use among older adults with hypertension.

Federman AD, Halm EA, Zhu C, Hochman T, Siu AL.

Am J Manag Care. 2006 Oct;12(10):611-8.

2.
3.
4.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
5.

Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus.

Tjia J, Briesacher BA.

J Am Geriatr Soc. 2008 Oct;56(10):1879-86. doi: 10.1111/j.1532-5415.2008.01917.x. Epub 2008 Sep 2.

6.

Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease.

Federman AD, Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ.

JAMA. 2001 Oct 10;286(14):1732-9.

PMID:
11594898
8.

Prevalence and predictors of utilization of community pharmacy generic drug discount programs.

Gatwood J, Tungol A, Truong C, Kucukarslan SN, Erickson SR.

J Manag Care Pharm. 2011 Jul-Aug;17(6):449-55.

10.

Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.

Blumberg DM, Prager AJ, Liebmann JM.

JAMA Ophthalmol. 2016 Feb;134(2):212-20. doi: 10.1001/jamaophthalmol.2015.5090.

PMID:
26720853
11.

Self-restriction of medications due to cost in seniors without prescription coverage.

Steinman MA, Sands LP, Covinsky KE.

J Gen Intern Med. 2001 Dec;16(12):793-9.

12.
13.
14.
15.

Family income and the impact of a children's health insurance program on reported need for health services and unmet health need.

Feinberg E, Swartz K, Zaslavsky A, Gardner J, Walker DK.

Pediatrics. 2002 Feb;109(2):E29.

PMID:
11826239
16.

Identifying widely covered drugs and drug coverage variation among Medicare part D formularies.

Tseng CW, Mangione CM, Brook RH, Keeler E, Dudley RA.

JAMA. 2007 Jun 20;297(23):2596-602.

17.

Impact of the Medicare modernization act on low-income persons.

Havrda DE, Omundsen BA, Bender W, Kirkpatrick MA.

Ann Intern Med. 2005 Oct 18;143(8):600-8.

PMID:
16230727
18.

Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.

Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM.

J Manag Care Spec Pharm. 2014 Mar;20(3):283-90.

19.

Employer drug benefit plans and spending on prescription drugs.

Joyce GF, Escarce JJ, Solomon MD, Goldman DP.

JAMA. 2002 Oct 9;288(14):1733-9. Erratum in: JAMA 2002 Nov 20;288(19):2409.

PMID:
12365957
20.

PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.

Cline RR, Worley MM, Schondelmeyer SW, Schommer JC, Larson TA, Uden DL, Hadsall RS.

Res Social Adm Pharm. 2010 Jun;6(2):130-42. doi: 10.1016/j.sapharm.2010.04.002.

PMID:
20511112

Supplemental Content

Support Center